These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 943223)

  • 21. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
    McKenna WJ; Kleinebenne A
    Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Amiodarone: pharmacology, clinical use and side effects].
    Popiliev I
    Vutr Boles; 1985; 24(5):17-25. PubMed ID: 3911581
    [No Abstract]   [Full Text] [Related]  

  • 24. [Amiodarone hydrochloride in the treatment of arrhythmia in pre-excitation syndromes].
    Telichowski C; Krzysztoń Z
    Wiad Lek; 1977 Jun; 30(12):955-8. PubMed ID: 883313
    [No Abstract]   [Full Text] [Related]  

  • 25. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of electrophysiologic effects and efficacy of single-dose intravenous and long-term oral amiodarone therapy in patients with AV nodal reentrant tachycardia.
    Gambhir DS; Bhargava M; Nair M; Arora R; Khalilullah M
    Indian Heart J; 1996; 48(2):133-7. PubMed ID: 8682552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor].
    Sokolov SF; Golitsyn SP; Malakhov VI; Bankuzov VA; Koltunova MI; Golitsyn LS
    Farmakol Toksikol; 1990; 53(3):57-60. PubMed ID: 2387385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amiodarone-induced 2 to 1 atrioventricular block in association with prolongation of the QT interval.
    McMahon CJ; Laird WP; Fenrich AL
    Cardiol Young; 2003 Jun; 13(3):305-7. PubMed ID: 12903882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A; Capestro F; Ciampani N; Fratadocchi GB; Mazzanti M; Costantini C; Molini E
    G Ital Cardiol; 1987 Aug; 17(8):690-8. PubMed ID: 3121426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of sequential antiarrhythmic treatment in sinus rhythm maintenance after successful electrocardioversion in patients with chronic non-valvular atrial fibrillation.
    Kosior D; Opolski G; Torbicki A
    Med Sci Monit; 2001; 7(1):68-73. PubMed ID: 11208496
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A toxic combination.
    Zeineh NS
    Am J Med; 2010 Aug; 123(8):707-8. PubMed ID: 20670723
    [No Abstract]   [Full Text] [Related]  

  • 32. [Amiodarone, a new anti-arrhythmia agent in arrhythmia associated with myocardial infarct].
    Watanabe Y; Katoh T
    Nihon Rinsho; 1983 Dec; 41(12):2766-70. PubMed ID: 6674562
    [No Abstract]   [Full Text] [Related]  

  • 33. Repetitive supraventricular tachycardia: clinical manifestations and response to therapy with amiodarone.
    Haines DE; Lerman BB; DiMarco JP
    Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):130-3. PubMed ID: 2419843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
    McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
    Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
    Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
    Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of amiodarone in children.
    Coumel P; Lucet V; Do Ngoc D
    Pacing Clin Electrophysiol; 1983 Sep; 6(5 Pt 1):930-9. PubMed ID: 6195613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intravenous amiodarone in the management of cardiac arrhythmias.
    Desai AD; Chun S; Sung RJ
    Ann Intern Med; 1997 Aug; 127(4):294-303. PubMed ID: 9265430
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of refractory life-threatening ventricular tachyarrhythmias by amiodarone.
    Nademanee K; Hendrickson JA; Cannom DS; Goldreyer BN; Singh BN
    Am Heart J; 1981 Jun; 101(6):759-68. PubMed ID: 7234654
    [No Abstract]   [Full Text] [Related]  

  • 39. Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.
    McKenna WJ; Harris L; Perez G; Krikler DM; Oakley C; Goodwin JF
    Br Heart J; 1981 Aug; 46(2):173-8. PubMed ID: 7196769
    [No Abstract]   [Full Text] [Related]  

  • 40. [ECG observations on terminating tachyarrhythmia by intravenous amiodarone].
    Xu ML
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):14-6. PubMed ID: 4006697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.